Sociedad Americana de Hirudoterapia

Learnings from the front line: early implementation experiences of the Central Queensland diabetes-related foot ulcer outpatient program

Implementation study published in Aust J Rural Health (2025)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportEnsayos clínicosKumar et al. · The Australian journal of rural health, 2025

Abstract

BACKGROUND: The 'Central Foot Hub' was operationalised in mid-February 2024 to provide multidisciplinary team (MDT) support from the Royal Brisbane and Women's Hospital (RBWH) to three hospital and health services (HHS) across Central Queensland. This model aimed to enhance diabetes-related foot disease (DFD) care by integrating virtual and local MDTs. AIM: This study presents early implementation learnings from frontline clinicians involved in the co-design, implementation and refinement of this innovative model-of-care (MOC). METHODS: A preparatory phase involved stakeholder engagement, service mapping and funding allocation to RBWH for recruitment. Site preparedness varied, influencing referral rates. A mixed-methods approach was used to evaluate challenges and successes, with input from local end-users. DISCUSSION: Key enablers included local champions, collective leadership and integration with existing providers. At Rockhampton Base Hospital, the MDT expanded subsequently improving care coordination. However, challenges such as funding constraints, hybrid health information systems, and technological barriers affected implementation. Discipline-specific insights highlighted the need for structured communication, local workforce expansion and ongoing refinement of MOC. CONCLUSION: The Central Foot Hub enhanced access to specialist care and optimised local service delivery for people living with DFD in Central Queensland. Sustainable scale-up will require additional funding, streamlined health information systems and continued collaboration between healthcare providers across HHS.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsHumansQueenslandDiabetic FootPatient Care TeamFemale

Resumen

Implementation-experience analysis of a diabetic-foot-ulcer outpatient program in rural Queensland including alternative-therapy considerations.

Por qué esto importa para la hirudoterapia

This study presented early implementation learnings from frontline clinicians involved in the co-design and establishment of a multidisciplinary team model for diabetes-related foot disease (DFD) care in Central Queensland. The model aimed to integrate virtual and local specialist teams to enhance care coordination, highlighting both the successes of local collaboration and the challenges of funding constraints and technological barriers. While diabetic foot ulcers are a significant clinical challenge, this article possesses no direct relevance to the American Society of Hirudotherapy. The research focuses strictly on healthcare service delivery, virtual care integration, and program management, without making any mention of leeches, wound management using hirudotherapy, or related biological therapies.

Citación

Learnings from the front line: early implementation experiences of the Central Queensland diabetes-related foot ulcer outpatient program.

Kumar et al. · The Australian journal of rural health, 2025

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.